Related Experiment Video
Updated: Jul 29, 2025

Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
Retinopathy of Prematurity and Glucose-6-Phosphate Dehydrogenase Activity: A Case-Control Study
Rajarajan Paulpandian1, Sourabh Dutta2, Reena Das3
1Neonatology Unit, Department of Pediatrics, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India.
Insights
Higher glucose-6-phosphate dehydrogenase (G6PD) activity in red blood cells is linked to retinopathy of prematurity (ROP) in premature infants. Increased G6PD levels elevate the risk of developing ROP.
Area of Science:
- Neonatal Medicine
- Biochemistry
- Ophthalmology
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- The etiology of ROP is multifactorial, involving factors like prematurity, oxygen exposure, and birth weight.
- Glucose-6-phosphate dehydrogenase (G6PD) is an enzyme crucial for red blood cell function.
Purpose of the Study:
- To investigate the association between red blood cell glucose-6-phosphate dehydrogenase (G6PD) activity and the occurrence of retinopathy of prematurity (ROP).
- To determine if G6PD activity is an independent predictor of ROP in preterm infants.
Main Methods:
- A case-control study was conducted in a Level-3 neonatal unit involving preterm infants (birth weight <2000g).
- Sixty infants with ROP (cases) and sixty without ROP (controls) were enrolled, excluding transfusion recipients.
- Quantitative assay of G6PD activity in red blood cells was performed as a candidate risk factor.
Main Results:
- Infants with ROP exhibited higher median G6PD activity compared to controls.
- G6PD activity showed a trend of increasing with ROP severity, being highest in ROP requiring treatment.
- Multivariable logistic regression identified G6PD activity (Adjusted OR 1.14) and shorter gestation as independent predictors of ROP.
Conclusions:
- Elevated red blood cell G6PD activity is independently associated with retinopathy of prematurity in preterm infants.
- Each 1 U/g Hb increase in G6PD activity was associated with a 14% increased odds of ROP.
- Severer forms of ROP correlate with higher G6PD activity levels, suggesting a potential role in ROP pathogenesis.
Objective:
To determine whether red blood cell glucose-6-phosphate dehydrogenase (G6PD) activity is associated with retinopathy of prematurity (ROP).
Methods:
This case-control study was conducted in a Level-3 neonatal unit. Subjects were inborn boys with birth weight <2000 g. "Cases" were consecutive subjects with ROP of any severity. "Controls" were consecutive unrelated subjects without ROP. Recipients of blood or exchange transfusions were excluded. Sixty cases (out of 98 screened) and 60 controls (out of 93 screened) were enrolled. G6PD activity (quantitative assay) as the candidate risk factor was evaluated.
Results:
Sixty cases with 60 controls [mean (SD) gestation 28.80 (2.2) and 30.60 (2.2) wk respectively] were compared. "Cases" had a higher median (1st, 3rd quartile) G6PD activity compared to "controls" [7.39 (4.7, 11.5) vs. 6.28 (4.2, 8.8) U/g Hb, p = 0.084]. G6PD activity was highest among ROP requiring treatment [8.68 (4.7, 12.3)] followed by ROP not requiring treatment [6.91 (4.4, 11.0)], followed by controls (plinear trend = 0.06). Gestation, birth weight, duration of oxygen, breastmilk feeding, and clinical sepsis were other variables associated with ROP on univariable analysis. On multivariable logistic regression, G6PD activity [Adjusted OR 1.14 (1.03, 1.25), p = 0.01] and gestation [Adjusted OR 0.74 (0.56, 0.97), p = 0.03] independently predicted ROP. C-statistic of the model was 0.76 (95% CI 0.67, 0.85).
Conclusions:
Higher G6PD activity was independently associated with ROP after adjusting for confounders. Each 1 U/g Hb increase in G6PD increased the odds of ROP by 14%. Severer forms of ROP were associated with higher levels of G6PD activity.
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Type 2 and Gestational
Inborn Errors of Metabolism

